M Legraverend - JoVE Visualize

Showing results (11-20 of 22) with videos related to

Pageof 3

Sort By:

Journal of Medicinal Chemistry|September 1, 1990

Synthesis of new (+-)-3,5-dihydroxypentyl nucleoside analogues from 1-amino-5-(benzyloxy)pentan-3-ol and their antiviral evaluationM Legraverend, H Boumchita, A Zerial, et al.

Expert Opinion on Emerging Drugs|July 2, 2005

Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitorsM L Andreola, C H Nguyen, M Ventura, et al.

Annales D'Urologie|January 1, 1986

[Cavernous hemangioma of the bladder in children. Apropos of a case]J M Legraverend, J P Canarelli, B Boudailliez, et al.

Bioorganic & Medicinal Chemistry|August 28, 1999

Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitorsM Legraverend, O Ludwig, E Bisagni, et al.

Chirurgie Pediatrique|January 1, 1985

[A new case of non-secreting adrenocortical tumor in a child]J P Canarelli, J C Pautard, B Pautard, et al.

Archives of Virology|May 5, 1999

Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virionsM Ventura, L Tarrago-Litvak, V Dollé, et al.

Journal D'Urologie|January 1, 1986

[Treatment of hydronephrosis in newborn infants. Apropos of 18 cases diagnosed by antenatal ultrasonography]J M Legraverend, J Ricard, B Boudailliez, et al.

Journal of Medicinal Chemistry|February 7, 2001

Cyclin-dependent kinase inhibition by new C-2 alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complexM Legraverend, P Tunnah, M Noble, et al.

Chirurgie Pediatrique|January 1, 1984

[Gardner syndrome treated by total colectomy with preservation of the internal sphincter. Apropos of 3 cases]J P Canarelli, P Descombes, J M Legraverend, et al.

Journal of Medicinal Chemistry|October 29, 2000

Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorsV Dollé, C H Nguyen, M Legraverend, et al.

Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:

Pageof 3

Journal of Medicinal Chemistry|September 1, 1990

Synthesis of new (+-)-3,5-dihydroxypentyl nucleoside analogues from 1-amino-5-(benzyloxy)pentan-3-ol and their antiviral evaluationM Legraverend, H Boumchita, A Zerial, et al.

Expert Opinion on Emerging Drugs|July 2, 2005

Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitorsM L Andreola, C H Nguyen, M Ventura, et al.

Annales D'Urologie|January 1, 1986

[Cavernous hemangioma of the bladder in children. Apropos of a case]J M Legraverend, J P Canarelli, B Boudailliez, et al.

Bioorganic & Medicinal Chemistry|August 28, 1999

Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitorsM Legraverend, O Ludwig, E Bisagni, et al.

Chirurgie Pediatrique|January 1, 1985

[A new case of non-secreting adrenocortical tumor in a child]J P Canarelli, J C Pautard, B Pautard, et al.

Archives of Virology|May 5, 1999

Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virionsM Ventura, L Tarrago-Litvak, V Dollé, et al.

Journal D'Urologie|January 1, 1986

[Treatment of hydronephrosis in newborn infants. Apropos of 18 cases diagnosed by antenatal ultrasonography]J M Legraverend, J Ricard, B Boudailliez, et al.

Journal of Medicinal Chemistry|February 7, 2001

Cyclin-dependent kinase inhibition by new C-2 alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complexM Legraverend, P Tunnah, M Noble, et al.

Chirurgie Pediatrique|January 1, 1984

[Gardner syndrome treated by total colectomy with preservation of the internal sphincter. Apropos of 3 cases]J P Canarelli, P Descombes, J M Legraverend, et al.

Journal of Medicinal Chemistry|October 29, 2000

Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorsV Dollé, C H Nguyen, M Legraverend, et al.

Pageof 3